---
layout: post
title: InteliCare (ASX:ICR) announces major board shakeup and new strategic direction
external_url: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02512017-6A1087436?access_token=83ff96335c2d45a094df02a206a39ff4
featured: true
date: '2022-04-21 17:41:49 +1000'
year: "2022"
categories: "linked"
tags:
- ASX
- ICR
- InteliCare
- health
- technology
- board-changes
- new-chair
- new-director
- Greg-Leach
- Neale-Fong
- Cam-Ansell
- restructure
- strategic
- direction
---

Health technology company, [InteliCare (ASX:ICR)](https://www2.asx.com.au/markets/company/ICR):

> announces important changes to its Board as part of the recent strategic restructuring of the business.

Including: 

> * ICR Founder and [Chair] Greg Leach to transition to Non-Executive Director
> * Appointment of [...] Dr Neale Fong as new Independent Non-Executive [Chair]
> * Appointment of [...] Cam Ansell as Independent None-Executive Director
> * Appointment of an ICR Advisory committee

What is the new board getting paid?

> [Chair] Fee - $90,000 per annum
> Non-Executive Director Fee â€” $45,000 per annum

See also: [InteliCare (ASX:ICR) appoints new CEO](https://asxwhisperer.com/linked/2022/04/12/inteli-care-asx-icr-appoints-new-ceo/) from 9 days ago.
